STOCK TITAN

1933 Inds Stock Price, News & Analysis

TGIFF OTC

Welcome to our dedicated page for 1933 Inds news (Ticker: TGIFF), a resource for investors and traders seeking the latest updates and insights on 1933 Inds stock.

News and updates for 1933 Industries Inc. (CSE:TGIF, OTC:TGIFF) focus on its role as a Nevada-based licensed wholesale producer of cannabis consumer products. The company’s releases highlight its cultivation and extraction activities at a 68,000 sq. ft. indoor facility and the performance of its flagship brands, particularly Alternative Medicine Association (AMA) and Level X, in the Nevada market.

Readers can expect news about financial results, where 1933 Industries reports on revenue, gross profit, margins and net income, along with commentary on operational efficiencies and cost-saving initiatives. The company has emphasized periods of positive income, consecutive profitable quarters and improvements in earnings, positioning these updates within the context of the Nevada cannabis market and broader industry conditions.

Another key news theme is the company’s capital structure and convertible debentures. Releases describe the issuance, repurchase and cancellation of unsecured convertible debentures, as well as reminders and guidance to debenture holders regarding conversion deadlines and terms. The company explains how debenture conversions and repurchases affect its outstanding liabilities, liquidity and ability to continue operating, and why conversion is viewed by the board as a constructive outcome for stakeholders.

News items also address regulatory and industry developments, including references to U.S. federal actions related to cannabis scheduling and amendments to the Farm Bill affecting hemp-derived products. 1933 Industries discusses how these changes may influence competition from hemp-derived THC products and create potential opportunities for licensed operators in legal states such as Nevada. For ongoing insight into the company’s operations, financial performance, balance sheet actions and regulatory commentary, this news feed provides a consolidated view of 1933 Industries’ public communications.

Rhea-AI Summary

1933 Industries (CSE: TGIF) has established a distribution agreement with CBD Plus to market its Canna Hemp™ wellness products in over 120 retail locations across the Midwest and South U.S. The one-year agreement includes a 45-day trial period, commencing immediately. This partnership aims to enhance Canna Hemp™'s presence in the rapidly growing CBD market, projected to reach $12.4 billion by 2023. 1933 Industries' President, Eugene Ruiz, expressed optimism about the collaboration, emphasizing quality and education in CBD wellness.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.26%
Tags
none
-
Rhea-AI Summary

1933 Industries Inc. announced the continuation of its private placement financing, initially disclosed on July 17, 2020. This vertically-integrated cannabis company focuses on cultivating and manufacturing cannabis consumer goods across various product formats. It operates through two subsidiaries, managing the entire value chain. The firm holds a 91% stake in the Alternative Medicine Association and 100% of Infused MFG LLC, offering a diverse portfolio of brands and licensing partnerships.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.46%
Tags
private placement

FAQ

What is the current stock price of 1933 Inds (TGIFF)?

The current stock price of 1933 Inds (TGIFF) is $0.0074 as of February 27, 2026.

What is the market cap of 1933 Inds (TGIFF)?

The market cap of 1933 Inds (TGIFF) is approximately 4.4M.

TGIFF Rankings

TGIFF Stock Data

4.41M
452.04M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Vancouver

TGIFF RSS Feed